Variant-Targeted Covid-19 Boosters Test the Promise of mRNA Technology
August 21st, 2022 | 🕒
https://www.ispeech.org/text.to.speech The U.K. last week became the first country to clear a modified Covid-19 vaccine targeting the Omicron variant, and
August 21st, 2022 | 🕒
https://www.ispeech.org/text.to.speech The U.K. last week became the first country to clear a modified Covid-19 vaccine targeting the Omicron variant, and
August 15th, 2022 | 🕒
https://www.ispeech.org/text.to.speech By Kosaku Narioka Daiichi Sankyo Co. shares rose sharply Monday morning after the Japanese drugmaker said an arbitrator ruled
February 4th, 2022 | 🕒
iSpeech.org The vaccines that have helped billions of people around the world to protect themselves from Covid-19 were a surprise
December 4th, 2021 | 🕒
iSpeech.org Are Covid-19 vaccines a failure? That’s the view in some media quarters amid breakthrough infections and new virus variants.
September 17th, 2021 | 🕒
https://www.ispeech.org When the Republic of Ghana received its first delivery of the Covid-19 vaccine, there was reason to doubt it
July 2nd, 2021 | 🕒
text to speech By Anthony O. Goriainoff Shares in Microsaic Systems PLC rose on Friday after the company said that
June 22nd, 2021 | 🕒
iSpeech.org By Adria Calatayud GlaxoSmithKline PLC said Tuesday that ViiV Healthcare, the specialist HIV company in which it holds a
April 3rd, 2021 | 🕒
iSpeech.org Credit Suisse Group AG A fire sale of stocks by a large U.S. investor burned Credit Suisse and Nomura
March 13th, 2021 | 🕒
iSpeech Text size These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10
June 26th, 2020 | 🕒
iSpeech A research institute run by China’s military received approval to conduct human clinical trials of a new Covid-19 vaccine
Gloss